SCHEMBL4904904

SCHEMBL4904904

O=C(COc1cc(F)cc(F)c1)Nc1ccc(O)cc1C(=O)O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.59
KDM4E B2RXH2 3/20 0.59
HSD17B10 Q99714 3/20 0.59
HCAR2 Q8TDS4 3/20 0.57
KMT2A Q03164 4/20 0.51
MEN1 O00255 3/20 0.51
DVL1 O14640 1/20 0.50
CASP3 P42574 1/20 0.50
SENP8 Q96LD8 1/20 0.50
SENP7 Q9BQF6 1/20 0.50
SENP6 Q9GZR1 1/20 0.50
NPC1 O15118 2/20 0.47
MAPT P10636 3/20 0.46
TP53 P04637 1/20 0.46
SERPINE1 P05121 1/20 0.44
RAB9A P51151 1/20 0.44
TSHR P16473 1/20 0.44
MAPK10 P53779 1/20 0.44
HPGD P15428 1/20 0.44
POLB P06746 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4910031 0.85 KMT2A (0.68) ALDH1A1KDM4EHSD17B10HCAR2KMT2A
SCHEMBL4914768 0.84 KDM4E (0.59) ALDH1A1KDM4EHSD17B10HCAR2KMT2A
SCHEMBL4912940 0.82 HCAR2 (0.58) ALDH1A1KDM4EHSD17B10HCAR2KMT2A
SCHEMBL4905601 0.82 HCAR2 (0.58) ALDH1A1KDM4EHSD17B10HCAR2KMT2A
SCHEMBL4905629 0.80 ALDH1A1 (0.65) ALDH1A1KDM4EHSD17B10HCAR2KMT2A
SCHEMBL4904826 0.79 KDM4E (0.63) ALDH1A1KDM4EHSD17B10HCAR2KMT2A
SCHEMBL3550521 0.79 PTPN1 (0.47) ALDH1A1HSD17B10HCAR2KMT2AMEN1
SCHEMBL4914734 0.79 SERPINE1 (0.62) ALDH1A1KDM4EHSD17B10HCAR2KMT2A
SCHEMBL4917374 0.79 MEN1 (0.66) ALDH1A1KDM4EHSD17B10HCAR2KMT2A
SCHEMBL4912968 0.78 KMT2A (0.69) ALDH1A1KDM4EHSD17B10HCAR2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080269333-A1 ANTHRANILIC ACID DERIVATIVES USEFUL IN TREATING INFECTION WITH HEPATITIS C VIRUS WYETH (US) 2008-10-30 US claimed
US-7408078-B2 Anthranilic acid derivatives useful in treating infection with hepatitis C virus WYETH (US) 2008-08-05 US claimed
US-20050004192-A1 Anthranilic acid derivatives useful in treating infection with hepatitis C virus VIROPHARMA INCORPORATED 2005-01-06 US claimed
WO-2004091724-A1 ANTHRANILIC ACID DERIVATIVES USEFUL IN TREATING INFECTION WITH HEPATITIS C VIRUS WYETH (US) 2004-10-28 WO claimed
US-20080269333-A1 ANTHRANILIC ACID DERIVATIVES USEFUL IN TREATING INFECTION WITH HEPATITIS C VIRUS WYETH (US) 2008-10-30 US disclosed
US-7408078-B2 Anthranilic acid derivatives useful in treating infection with hepatitis C virus WYETH (US) 2008-08-05 US disclosed
US-20050004192-A1 Anthranilic acid derivatives useful in treating infection with hepatitis C virus VIROPHARMA INCORPORATED 2005-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050004192-A1 Anthranilic acid derivatives useful in treating infection with hepatitis C virus HCCS, ALAD, HAVCR2 ALDH1A1 271/4885KDM4E 2214/4885HSD17B10 506/4885
US-20080269333-A1 ANTHRANILIC ACID DERIVATIVES USEFUL IN TREATING INFECTION WITH HEPATITIS C VIRUS HCCS, ALAD, HAVCR2 ALDH1A1 271/4885KDM4E 2214/4885HSD17B10 506/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.